Replies to post #94358 on Creative Medical Technology Holdings Inc (CELZ)

[justdafactss]

Nah, why didn't CELZ say "TOLERANCE" was the primary endpoint that was met?

The data analysis demonstrated that primary end-point of the study was met.
https://www.otcmarkets.com/stock/CELZ/news/Creative-Medical-Technology-Holdings-Reports-completion-and-submission-of-Clinical-Trial-Data-on-CaverStem-Procedure-for?id=239217

No mention of the "SECONDARY" endpoint right?

Isn't this the European paper CELZ referred to on their website awhile back?

Tolerance was the primary endpoint.
https://www.europeanurology.com/article/S0302-2838(15)00934-3/fulltext